Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

September 30, 2026

Conditions

Dry Eye Disease

Interventions

DEVICE

BUFY01 eye drops in single-dose containers

1 to 2 drops in each eye, as often as needed

DEVICE

SVS20 eye drops in single-dose containers

1 to 2 drops in each eye, as often as needed

All Listed Sponsors

lead

TRB Chemedica International SA

INDUSTRY

NCT05865379 - Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease | Biotech Hunter | Biotech Hunter